Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine hydrochloride extended-release tablets for ADHD (Phase III, China)
CTR20191871Phase 3Completed
- Sponsor
- Lipin Pharmaceutical
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clonidine in attention deficit hyperactivity disorder (ADHD), sponsored by Lipin Pharmaceutical. Started Nov 2019; status: completed.
02
Drugs
clonidine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on CTR20191871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191871.